- B2B
- Growth StageExpanding market presence
Green & Grow careers
GGI is a startup in the Agriculture Technology sector commercializing a biologically derived technology, branded Agriplier, to improve crop yields.
The go-to market strategy we are executing centers on a number of expanding partnership relationships with industry leaders in the Ag sector, distributors, selected end-users and multiple independent research teams. Through these relationships, we have demonstrated across multiple years of trial data that GGI’s Agriplier® Technology improves yields above and beyond the current market standard seed treatment and soil applied products in use today. Agriplier® is a compelling offer for integration into the next generation of these product packages.
During independent trials, GGI products were the #1 performing yield enhancement seed treatment product for Corn in 2013 and Soybean in both 2013 and 2014. Significant yield increases have also been obtained across a range of fruit and vegetable crops.
The go-to market strategy we are executing centers on a number of expanding partnership relationships with industry leaders in the Ag sector, distributors, selected end-users and multiple independent research teams. Through these relationships, we have demonstrated across multiple years of trial data that GGI’s Agriplier® Technology improves yields above and beyond the current market standard seed treatment and soil applied products in use today. Agriplier® is a compelling offer for integration into the next generation of these product packages.
During independent trials, GGI products were the #1 performing yield enhancement seed treatment product for Corn in 2013 and Soybean in both 2013 and 2014. Significant yield increases have also been obtained across a range of fruit and vegetable crops.
Green & Grow hasn't added any jobs yet
Get notified when Green & Grow posts new jobs.
Valuation
$0
Funded over
1 round
Latest round
Series B (Aug 2014)
Omeros • Seattle • $220k – $240k • 6 days ago
Interplay Learning • Austin • $80k – $90k • 2 weeks ago
Ptc Therapeutics • United States • $119k – $145k • 3 weeks ago
Eli Lilly • Indianapolis • $69k – $165k • 3 weeks ago
Sanofi Aventis • Cambridge • 4 weeks ago
